Wednesday, January 16, 2008

Flu Vaccine: Cell Death Suppression Increases Efficacy Of M2 Vaccines

Significant public attention has recently been focused on the development of new anti-influenza vaccines that provide protection against a broad spectrum of viral strains. One proposed strategy is to utilize conserved viral protein, M2. Clinical trials of M2-containing influenza vaccines were recently initiated by US and European companies.

Full Article


No comments: